These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34404022)

  • 1. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.
    van 't Hullenaar CAA; Coerver E; Kalkers NF; van Kempen Z; Koch M; Uitdehaag BMJ; Killestein J; Strijbis EMM
    Mult Scler Relat Disord; 2021 Oct; 55():103165. PubMed ID: 34404022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting clinically-relevant changes in progressive multiple sclerosis.
    Bosma LV; Sonder JM; Kragt JJ; Polman CH; Uitdehaag BM
    Mult Scler; 2015 Feb; 21(2):171-9. PubMed ID: 25013153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.
    Hoogervorst EL; Eikelenboom MJ; Uitdehaag BM; Polman CH
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):439-42. PubMed ID: 12640058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis.
    Kragt JJ; van der Linden FA; Nielsen JM; Uitdehaag BM; Polman CH
    Mult Scler; 2006 Oct; 12(5):594-8. PubMed ID: 17086905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.
    Hoogervorst EL; de Jonge P; Jelles B; Huyse FJ; Heeres I; van der Ploeg HM; Uitdehaag BM; Polman CH
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):20-4. PubMed ID: 12486260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.
    Theodorsdottir A; Larsen PV; Nielsen HH; Illes Z; Ravnborg MH
    Acta Neurol Scand; 2022 Mar; 145(3):332-347. PubMed ID: 34799851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.
    Motl R; Neal W; Backus D; Hebert J; McCully K; Bethoux F; Plummer P; Ng A; Lowman J; Schmidt H; McBurney R; Cutter G
    BMC Neurol; 2024 Oct; 24(1):383. PubMed ID: 39390466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L; Kragt JJ; Polman CH; Uitdehaag BM
    Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
    Rossier P; Wade DT
    Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
    Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
    Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
    Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
    Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
    Pappalardo A; Patti F
    Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
    Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH
    Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.
    Theodorsdottir A; Nielsen HH; Ravnborg MH; Illes Z
    Mult Scler Relat Disord; 2023 Mar; 71():104550. PubMed ID: 36842312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis.
    Molenaar PCG; Strijbis EMM; van Munster CEP; Uitdehaag BMJ; Kalkers NF
    Mult Scler Relat Disord; 2022 May; 61():103725. PubMed ID: 35421639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice.
    Baldassari LE; Nakamura K; Moss BP; Macaron G; Li H; Weber M; Jones SE; Rao SM; Miller D; Conway DS; Bermel RA; Cohen JA; Ontaneda D; McGinley MP
    Mult Scler Relat Disord; 2020 Feb; 38():101525. PubMed ID: 31759186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.
    Hoogervorst EL; Kalkers NF; Cutter GR; Uitdehaag BM; Polman CH
    Mult Scler; 2004 Feb; 10(1):55-60. PubMed ID: 14760953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.